Weild’s keynote explored the intersection of the democratization of capital and healthcare innovation, which has sparked a new way for medtech startups to raise money outside of traditional venture capital or private equity paths. David also highlights how the JOBS Act is changing the healthtech and pharmaceutical industry. "It's gratifying to see so many Medtech companies using the JOBS Act since we created it in large part to fund innovative growth companies and social impact."
David Weild IV is a stock market expert best known for his position as Vice Chairman of NASDAQ. He is currently the Founder, Chairman and CEO of Weild & Co. Inc., parent company of the investment banking firm Weild Capital, LLC (dba Weild & Co.)[1] Weild is also known as the "father" of the JOBS Act, and has been involved in drafting legislation for the US Congress.
David Weild IV is a stock market expert best known for his position as Vice Chairman of NASDAQ. He is currently the Founder, Chairman and CEO of Weild & Co. Inc., parent company of the investment banking firm Weild Capital, LLC (dba Weild & Co.)[1] Weild is also known as the "father" of the JOBS Act, and has been involved in drafting legislation for the US Congress.
Weild’s keynote explored the intersection of the democratization of capital and healthcare innovation, which has sparked a new way for medtech startups to raise money outside of traditional venture capital or private equity paths. David also highlights how the JOBS Act is changing the healthtech and pharmaceutical industry. "It's gratifying to see so many Medtech companies using the JOBS Act since we created it in large part to fund innovative growth companies and social impact."
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy